These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1975165)

  • 1. Prognostic value of phenotyping by Ber-H2, Leu-M1, EMA in Hodgkin's disease.
    de Mascarel I; Trojani M; Eghbali H; Coindre JM; Bonichon F
    Arch Pathol Lab Med; 1990 Sep; 114(9):953-5. PubMed ID: 1975165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bauhinia purpurea--a new paraffin section marker for Reed-Sternberg cells of Hodgkin's disease. A comparison with Leu-M1 (CD15), LN2 (CD74), peanut agglutinin, and Ber-H2 (CD30).
    Sarker AB; Akagi T; Jeon HJ; Miyake K; Murakami I; Yoshino T; Takahashi K; Nose S
    Am J Pathol; 1992 Jul; 141(1):19-23. PubMed ID: 1352944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies in the diagnosis of Hodgkin's disease. The search for a rational panel.
    Chittal SM; Caverivière P; Schwarting R; Gerdes J; Al Saati T; Rigal-Huguet F; Stein H; Delsol G
    Am J Surg Pathol; 1988 Jan; 12(1):9-21. PubMed ID: 2827535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paraffin section markers for Reed-Sternberg cells. A comparative study of peanut agglutinin, Leu-M1, LN-2, and Ber-H2.
    Ree HJ; Neiman RS; Martin AW; Dallenbach F; Stein H
    Cancer; 1989 May; 63(10):2030-6. PubMed ID: 2564804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD30-positive, anaplastic large-cell lymphomas that express CD15 but lack CD45. A possible diagnostic pitfall.
    Perkins PL; Ross CW; Schnitzer B
    Arch Pathol Lab Med; 1992 Nov; 116(11):1192-6. PubMed ID: 1359849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD30-positive T-cell lymphomas co-expressing CD15: an immunohistochemical analysis.
    Gorczyca W; Tsang P; Liu Z; Wu CD; Dong HY; Goldstein M; Cohen P; Gangi M; Weisberger J
    Int J Oncol; 2003 Feb; 22(2):319-24. PubMed ID: 12527929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of the epithelial membrane antigen (EMA) in the case of Hodgkin's disease.
    Touhami H; Sotto JJ; Sotto MF; Couderc P; Keddari E; Brahimi S; Kubisz P
    Neoplasma; 1991; 38(4):433-7. PubMed ID: 1922575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hodgkin's disease and CD30-positive anaplastic large cell lymphomas--a continuous spectrum of malignant disorders. A quantitative morphometric and immunohistologic study.
    Leoncini L; Del Vecchio MT; Kraft R; Megha T; Barbini P; Cevenini G; Poggi S; Pileri S; Tosi P; Cottier H
    Am J Pathol; 1990 Nov; 137(5):1047-57. PubMed ID: 2173409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The immunohistochemistry of Hodgkin's disease.
    Said JW
    Semin Diagn Pathol; 1992 Nov; 9(4):265-71. PubMed ID: 1362283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinction between carcinoma cells and mesothelial cells in serous effusions. Usefulness of immunohistochemistry.
    Tickman RJ; Cohen C; Varma VA; Fekete PS; DeRose PB
    Acta Cytol; 1990; 34(4):491-6. PubMed ID: 2197840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical analysis of Hodgkin's disease using microwave heating.
    Charalambous C; Singh N; Isaacson PG
    J Clin Pathol; 1993 Dec; 46(12):1085-8. PubMed ID: 7904271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory malignant fibrous histiocytoma: distinction from Hodgkin's disease and non-Hodgkin's lymphoma by a panel of leukocyte markers.
    Khalidi HS; Singleton TP; Weiss SW
    Mod Pathol; 1997 May; 10(5):438-42. PubMed ID: 9160307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphological and immunohistochemical investigation of non-Hodgkin's lymphoma combined with Hodgkin's disease.
    Hansmann ML; Fellbaum C; Hui PK; Lennert K
    Histopathology; 1989 Jul; 15(1):35-48. PubMed ID: 2548946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of CD30 (Ki-1/Ber-H2) expression in primary cutaneous large-cell lymphomas of T-cell origin. A clinicopathologic and immunohistochemical study in 20 patients.
    Beljaards RC; Meijer CJ; Scheffer E; Toonstra J; van Vloten WA; van der Putte SC; Geerts ML; Willemze R
    Am J Pathol; 1989 Dec; 135(6):1169-78. PubMed ID: 2556926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytomegalovirus-infected cells express Leu-M1 antigen. A potential source of diagnostic error.
    Rushin JM; Riordan GP; Heaton RB; Sharpe RW; Cotelingam JD; Jaffe ES
    Am J Pathol; 1990 May; 136(5):989-95. PubMed ID: 1972001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophages in Hodgkin's lymphoma.
    Kadin ME
    N Engl J Med; 2010 Jun; 362(22):2135-6; author reply 2136. PubMed ID: 20527059
    [No Abstract]   [Full Text] [Related]  

  • 17. Utility of combining antigranulocyte with antileukocyte antibodies in differentiating Hodgkin's disease from non-Hodgkin's lymphoma.
    Medeiros LJ; Weiss LM; Warnke RA; Dorfman RF
    Cancer; 1988 Dec; 62(12):2475-81. PubMed ID: 2973368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunochemical diagnosis of hepatic localizations in malignant lymphoid hematologic diseases. Study of 80 cases].
    Voigt JJ; Vinel JP; Caverivière P; Pradère B; Chittal S; al Saati T; Calès P; Delsol G
    Gastroenterol Clin Biol; 1989 Apr; 13(4):343-52. PubMed ID: 2661293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophages in Hodgkin's lymphoma.
    Tsubokura M; Kodama Y; Kami M
    N Engl J Med; 2010 Jun; 362(22):2135; author reply 2136. PubMed ID: 20519687
    [No Abstract]   [Full Text] [Related]  

  • 20. Macrophages in Hodgkin's lymphoma.
    Pazianas M
    N Engl J Med; 2010 Jun; 362(22):2135; author reply 2136. PubMed ID: 20527079
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.